1. Duan, Qing-Qing, Wang, Han, Su, Wei-Ming, Wang, Yi, Chen, Yong-Ping. 2024. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro. In BMC medicine, 22, 96. doi:10.1186/s12916-024-03314-1. https://pubmed.ncbi.nlm.nih.gov/38443977/
2. Yeo, See Cheng, Barratt, Jonathan. 2023. The contribution of a proliferation-inducing ligand (APRIL) and other TNF superfamily members in pathogenesis and progression of IgA nephropathy. In Clinical kidney journal, 16, ii9-ii18. doi:10.1093/ckj/sfad200. https://pubmed.ncbi.nlm.nih.gov/38053976/
3. Zhong, Zhong, Feng, Shao-Zhen, Xu, Ri-Cong, Yu, Xue-Qing, Li, Ming. . Association of TNFSF13 polymorphisms with IgA nephropathy in a Chinese Han population. In The journal of gene medicine, 19, . doi:10.1002/jgm.2966. https://pubmed.ncbi.nlm.nih.gov/28636766/
4. Chen, Rui, Wang, Xinxing, Dai, Ziyu, Zhang, Hao, Cheng, Quan. 2021. TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas. In Frontiers in immunology, 12, 713757. doi:10.3389/fimmu.2021.713757. https://pubmed.ncbi.nlm.nih.gov/34712225/
5. Niu, Dan, Ren, Yongchao, Xie, Liyi, Lv, Jia, Li, Shengbin. . Association between CCDC132, FDX1 and TNFSF13 gene polymorphisms and the risk of IgA nephropathy. In Nephrology (Carlton, Vic.), 20, 908-15. doi:10.1111/nep.12611. https://pubmed.ncbi.nlm.nih.gov/26370181/
6. Lin, Hui-Yu, Kuei, Chia-Hao, Lee, Hsun-Hua, Chen, Chi-Long, Lin, Yuan-Feng. 2020. TNFSF13 upregulation confers chemotherapeutic resistance via triggering autophagy initiation in triple-negative breast cancer. In Journal of molecular medicine (Berlin, Germany), 98, 1255-1267. doi:10.1007/s00109-020-01952-5. https://pubmed.ncbi.nlm.nih.gov/32671412/